Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
Clinical trial NCT07010159 · RECRUITING
Trial details
- NCT number
- NCT07010159
- Sponsor
- Kiniksa Pharmaceuticals International, plc
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-25
- Primary completion
- 2027-12-31
- Enrollment
- 325
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.